Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 7, 2026; 32(33): 118185
Published online Sep 7, 2026. doi: 10.3748/wjg.118185
Published online Sep 7, 2026. doi: 10.3748/wjg.118185
Figure 2 The levels of urinary N1, N12-diacetylspermine concentrations.
A: Gastric cancer patients vs healthy controls and patients with benign gastrointestinal diseases; B: Colorectal cancer patients vs healthy controls and patients with benign gastrointestinal diseases. aP < 0.05, bP < 0.01, cP < 0.001. BGD: Benign gastrointestinal diseases; GC: Gastric cancer; CRC: Colorectal cancer.
- Citation: Zheng HZ, Wang P, Zheng HJ, Wang ZQ, Li QX, Chen HW, Chen HQ, Lei QC. Urinary N1, N12-diacetylspermine as a potential tumor biomarker for gastric and colorectal cancer. World J Gastroenterol 2026; 32(33): 118185
- URL: https://www.wjgnet.com/1007-9327/full/v32/i33/118185.htm
- DOI: https://dx.doi.org/10.3748/wjg.118185